Pablo Feuillet

Placeholder

Assistant Professor of Medicine

Email: pablo.feuillet@uttyler.edu
Department: Medicine
Additional Department: Infectious Diseases

Biography:

Dr. Pablo Feuillet is a board-certified infectious disease doctor, with over 26 years of experience in infectious diseases, working most of the time in San Antonio area but also in South and West Texas where he had training exposure to a great variety of infectious diseases, complications, and clinical challenges to provide therapy.

Dr. Feuillet has been closely involved with providing services in infectious diseases through telemedicine, offering this specialty to distant communities with difficult access to a large hospitals or multispecialty facilities. After the COVID pandemic, several states joined the Interstate Medical Compact Licensure (IMCL), including the State of Texas in June 2021. As of August 2025, the IMCL includes 45 States plus the District of Columbia and Guam, expanding the possibility to offer this specialty beyond our imagination.

Clinical/Research Interests

  • Mycobacterium tuberculosis
  • Atypical Mycobacterium infections
  • Osteomyelitis/septic joint infections
  • Group A streptococcal infections and MRSA
  • Coccidioidomycosis
  • Histoplasmosis
  • Cryptococcal infections and other fungal infections,
  • Telemedicine
  • Outpatient infusion therapy

Degrees

  • MD, Escuela Colombiana de Medicina/Universidad del Bosque, Bogota, Colombia
  • Internal Medicine Residency, Jackson Memorial Hospital/ University of Miami, Florida
  • Fellowship, University of Texas Health Science Center at San Antonio, Texas
  • An observational evaluation of the implementation of an inpatient dalbavancin program at a community teaching hospital.

Submitted for publication to the Journal of American Pharmacist Association on August 27, 2025, and a poster presented to the Texas Society of Health System Pharmacists in April 2024.

  • Evolution of Human and nonhuman primate C-C chemokine receptor 5 gene and mRNA. 

The Journal of Biological Chemistry.  Vol. 275, #25, Issue of June 23,  pp 18946–18961, 2000.

  • Genealogy of the CCR 5 locus and chemokine system gene variants associated with altered rates of HIV–1 disease progression. 

Nature medicine, volume 4, #7 pp 786–793 July 1998.

  • Epidemiology of Arterial Hypertension in the hospital population.

Acta Medica Colombiana, Vol. 11, #4, supplement July - August 1986.